trending Market Intelligence /marketintelligence/en/news-insights/trending/v82Dv0KlNu-IuMeKxY7nLA2 content esgSubNav
In This List

Aevi Genomic Medicine completes $28M private placement

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Aevi Genomic Medicine completes $28M private placement

Aevi Genomic Medicine Inc. completed its private placement of common shares and warrants for proceeds of $28 million, before expenses.

The Children's Hospital of Philadelphia Foundation was the lead investor.

Aevi Genomic plans to use net proceeds for the development of its two lead clinical programs and other product candidates, to support its collaboration with Children's Hospital of Philadelphia, and for general corporate purposes.

Jefferies LLC served as financial adviser to Aevi Genomic for the transaction and Evercore LLC served as financial adviser to the Children's Hospital of Philadelphia Foundation.